Pharchoice Therapeutics

Pharchoice Therapeutics Collaborates with the School of Basic Medicine of the Second Military Medical University and the School of Medicine of Shanghai Jiao Tong University to Develop Recombinant ACE2-Ig Antibody for Neutralizing SARS-CoV-2 Pseudovirus.